Drug details
Vyzulta (latanoprostene bunod ophthalmic solution)
type of Antiglaucoma, Prostaglandin Agonists
Vyzulta (latanoprostene bunod ophthalmic solution) 0.024%, for topical ophthalmic use is a prostaglandin analog indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- eye redness,
- eye swelling,
- severe discomfort,
- red, swollen, or itchy eyelids,
- crusting or drainage from the eye,
- sudden vision changes, and
- severe pain, burning, stinging, or irritation after using the medicine
The following drugs are related to Vyzulta, either as a replacement or used together:
- Diamox Sequels (acetazolamide xr)
- Azopt (brinzolamide ophthalmic suspension)
- Durysta (bimatoprost implant)
- Lumigan (bimatoprost ophthalmic solution 0.03% for glaucoma)
- Miostat (carbachol intraocular solution)
- Lodosyn (carbidopa)
- Sinemet (carbidopa-levodopa)
- Sinemet CR (carbidopa-levodopa sustained release)
- Trusopt (dorzolamide hydrochloride ophthalmic solution)
- Xelpros (latanoprost ophthalmic emulsion)
- Omlonti (omidenepag isopropyl ophthalmic solution)